Articles amb requisits d'accés públic - Salvatore OddoMés informació
TotalNIHCIHRNSFVAEuropean CommissionGovernment of ItalySNSFUSEDHHMIAHAFWFFRQSTelethonVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKParkinson's UKWellcomeWorldwide Cancer Research, UKDoris Duke Charitable FoundationANRMichael J Fox FoundationAutism Speaks Inc, USA
No estan disponibles en cap lloc: 5
Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice
JR Lopez, A Lyckman, S Oddo, FM LaFerla, HW Querfurth, A Shtifman
Journal of neurochemistry 105 (1), 262-271, 2008
Requisits: US National Institutes of Health
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice
DX Medina, ME Orr, S Oddo
Neurobiology of aging 35 (1), 79-87, 2014
Requisits: US National Institutes of Health
Differential activation of the mTOR/autophagy pathway predicts cognitive performance in APP/PS1 mice
RS Vartak, A Rodin, S Oddo
Neurobiology of Aging 83, 105-113, 2019
Requisits: US National Institutes of Health
Can we treat neurodegenerative proteinopathies by enhancing protein degradation?
S Engelender, L Stefanis, S Oddo, A Bellucci
Movement Disorders 37 (7), 1346-1359, 2022
Requisits: European Commission, Government of Italy, Michael J Fox Foundation
Paving the way for new clinical trials for Alzheimer’s Disease
C Branca, S Oddo
Biological Psychiatry 81 (2), 88-89, 2017
Requisits: US National Institutes of Health
Disponibles en algun lloc: 53
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Requisits: Swiss National Science Foundation, US National Institutes of Health, US …
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau: effects on cognitive impairments
A Caccamo, S Majumder, A Richardson, R Strong, S Oddo
Journal of Biological Chemistry 285 (17), 13107-13120, 2010
Requisits: US National Institutes of Health
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits
S Majumder, A Richardson, R Strong, S Oddo
PloS one 6 (9), e25416, 2011
Requisits: US National Institutes of Health
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies
A Caccamo, A Magrì, DX Medina, EV Wisely, MF López‐Aranda, AJ Silva, ...
Aging cell 12 (3), 370-380, 2013
Requisits: US National Institutes of Health
Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology
FE McAlpine, JK Lee, AS Harms, KA Ruhn, M Blurton-Jones, J Hong, ...
Neurobiology of disease 34 (1), 163-177, 2009
Requisits: US National Institutes of Health
The ubiquitin‐proteasome system in Alzheimer's disease
S Oddo
Journal of cellular and molecular medicine 12 (2), 363-373, 2008
Requisits: US National Institutes of Health
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease
A Caccamo, MA Maldonado, AF Bokov, S Majumder, S Oddo
Proceedings of the National Academy of Sciences 107 (52), 22687-22692, 2010
Requisits: US National Institutes of Health
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
R Belfiore, A Rodin, E Ferreira, R Velazquez, C Branca, A Caccamo, ...
Aging cell 18 (1), e12873, 2019
Requisits: US National Institutes of Health
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: an in situ cerebral perfusion study
M Ouellet, V Emond, CT Chen, C Julien, F Bourasset, S Oddo, F LaFerla, ...
Neurochemistry international 55 (7), 476-482, 2009
Requisits: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
The role of mTOR signaling in Alzheimer disease
S Oddo
Frontiers in bioscience (Scholar edition) 4, 941, 2012
Requisits: US National Institutes of Health
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice
MC Janelsins, MA Mastrangelo, KM Park, KL Sudol, WC Narrow, S Oddo, ...
The American journal of pathology 173 (6), 1768-1782, 2008
Requisits: US National Institutes of Health
Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
AC McKee, I Carreras, L Hossain, H Ryu, WL Klein, S Oddo, FM LaFerla, ...
Brain research 1207, 225-236, 2008
Requisits: US National Institutes of Health
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity
DX Medina, A Caccamo, S Oddo
Brain pathology 21 (2), 140-149, 2011
Requisits: US National Institutes of Health
Lifelong rapamycin administration ameliorates age‐dependent cognitive deficits by reducing IL‐1β and enhancing NMDA signaling
S Majumder, A Caccamo, DX Medina, AD Benavides, MA Javors, E Kraig, ...
Aging cell 11 (2), 326-335, 2012
Requisits: US National Institutes of Health
ACAT1 gene ablation increases 24 (S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD
EY Bryleva, MA Rogers, CCY Chang, F Buen, BT Harris, E Rousselet, ...
Proceedings of the National Academy of Sciences 107 (7), 3081-3086, 2010
Requisits: US National Institutes of Health, Canadian Institutes of Health Research
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic